Peptides Clarified

How to evaluate a telehealth provider

A practical checklist for assessing an online weight-loss or peptide provider — licensing, pricing transparency, medication sourcing, and disclosures.

By Peptides Clarified Editorial — Editorial sourcing review — licensed clinical review pending. Reviewed July 24, 2026.

Telehealth has made it far easier to get prescriptions for GLP-1 medications and other treatments. It has also made it easier for low-quality or misleading operations to reach patients. Here is a practical checklist you can use to evaluate any online provider.

1. Licensing and clinician involvement

  • Is an actual licensed clinician reviewing your information and prescribing?
  • Are the clinicians licensed in your state?
  • Is there a way to reach a clinician with questions after you start?

2. Pricing transparency

  • Can you see the full cost — program/membership fee and medication — before you commit?
  • Are recurring charges clearly disclosed?
  • Are there required add-on fees?

Providers that hide the total cost until after you sign up deserve extra skepticism.

3. Medication sourcing

  • Does the provider tell you whether you are getting an FDA-approved or a compounded medication? (See our guide on FDA-approved vs. compounded drugs.)
  • If compounded, which licensed pharmacy prepares it?
  • Does the provider make an explicit, honest disclosure that compounded drugs are not FDA-approved?

4. Cancellation and commitments

  • Can you cancel anytime, or are you locked into a multi-month commitment?
  • What happens to any prepaid balance if you stop for medical reasons?

5. Marketing red flags

  • Guaranteed results, dramatic "before/after" claims, or countdown-timer urgency.
  • Pressure to buy larger multi-month packages immediately.
  • Claims that a compounded or unapproved product is "the same as" or "better than" an approved one without evidence.

6. Your own safety

  • Would the provider know about your other medications and conditions?
  • Is there a plan for monitoring and side effects?

Use these questions as a starting point and bring anything you are considering to a licensed clinician. This guide is general education, not medical advice.

Sources

  1. 1.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss — U.S. Food and Drug Administration. Government agencyAccessed July 24, 2026.
  2. 2.FDA Warns Telehealth Companies Against Illegal Marketing of Compounded GLP-1s — U.S. Food and Drug Administration. Government agencyAccessed July 24, 2026.
Last reviewed (yesterday)